drugset / Trial / NCT00003968
Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer
NaSingle-groupOpen-labelTreatment
Summary
Phase II trial to study the effectiveness of bryostatin 1 in treating patients who have metastatic kidney cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
Timeline
- Start
- 1999-06
- Primary completion
- 2003-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | bryostatin 1 | Small molecule | — | Intravenous |